Welcome to our dedicated page for ETF SER SOLUTIONS news (Ticker: CLOC), a resource for investors and traders seeking the latest updates and insights on ETF SER SOLUTIONS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ETF SER SOLUTIONS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ETF SER SOLUTIONS's position in the market.
Advisors Asset Management (NYSE: CLOC) launched the AAM Crescent CLO ETF (CLOC) on October 23, 2025, offering investors access to liquid, investment-grade tranches of collateralized loan obligations (CLOs).
The ETF is subadvised by Crescent Capital Group, which the announcement says has 30+ years of CLO experience, and carries a net expense ratio of 0.18% as of 10/23/25, described as the lowest-cost CLO ETF in the market. CLOC is positioned for income-seeking investors within AAM's 'Resilient Income' ETF suite.
FAQ
What is the current stock price of ETF SER SOLUTIONS (CLOC)?
